Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $47.7B |
| FY2017, ended Dec 31, 2017 | $88.4B |
| FY2018, ended Dec 31, 2018 | $98.7B |
| FY2019, ended Dec 31, 2019 | $127B |
| FY2020, ended Dec 31, 2020 | $274B |
| FY2021, ended Dec 31, 2021 | $220B |
| FY2022, ended Dec 31, 2022 | $80.6B |
| FY2023, ended Dec 31, 2023 | $65.8B |
| FY2024, ended Dec 31, 2024 | $84.4B |
| FY2025, ended Dec 31, 2025 | $53.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $43.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $10.8B |
| FY2017, ended Dec 31, 2017 | $13.1B |
| FY2018, ended Dec 31, 2018 | $15.5B |
| FY2019, ended Dec 31, 2019 | $17.8B |
| FY2020, ended Dec 31, 2020 | $21.5B |
| FY2021, ended Dec 31, 2021 | $25.4B |
| FY2022, ended Dec 31, 2022 | $27.5B |
| FY2023, ended Dec 31, 2023 | $29.8B |
| FY2024, ended Dec 31, 2024 | $31.8B |
| FY2025, ended Dec 31, 2025 | $33.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $34.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.40B | $2.49B |
| FY2017, ended Dec 31, 2017 | $1.79B | $1.86B |
| FY2018, ended Dec 31, 2018 | $2.06B | $4.66B |
| FY2019, ended Dec 31, 2019 | $2.46B | $3.37B |
| FY2020, ended Dec 31, 2020 | $4.20B | $5.35B |
| FY2021, ended Dec 31, 2021 | $4.17B | $4.89B |
| FY2022, ended Dec 31, 2022 | $2.42B | $5.11B |
| FY2023, ended Dec 31, 2023 | $4.25B | $4.22B |
| FY2024, ended Dec 31, 2024 | $4.15B | $6.77B |
| FY2025, ended Dec 31, 2025 | $5.23B | $5.56B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $4.73B | $6.30B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.59B |
| FY2017, ended Dec 31, 2017 | $2.88B |
| FY2018, ended Dec 31, 2018 | $7.58B |
| FY2019, ended Dec 31, 2019 | $7.35B |
| FY2020, ended Dec 31, 2020 | $4.79B |
| FY2021, ended Dec 31, 2021 | $5.20B |
| FY2022, ended Dec 31, 2022 | $7.78B |
| FY2023, ended Dec 31, 2023 | $9.08B |
| FY2024, ended Dec 31, 2024 | $6.66B |
| FY2025, ended Dec 31, 2025 | $8.05B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $7.16B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $0 |
| FY2017, ended Dec 31, 2017 | $1.00B |
| FY2018, ended Dec 31, 2018 | $2.00B |
| FY2019, ended Dec 31, 2019 | $4.96B |
| FY2020, ended Dec 31, 2020 | $8.94B |
| FY2021, ended Dec 31, 2021 | $8.05B |
| FY2022, ended Dec 31, 2022 | $10.4B |
| FY2023, ended Dec 31, 2023 | $9.68B |
| FY2024, ended Dec 31, 2024 | $9.88B |
| FY2025, ended Dec 31, 2025 | $11.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $13.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 31.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.21B |
| FY2017, ended Dec 31, 2017 | 1.20B |
| FY2018, ended Dec 31, 2018 | 1.17B |
| FY2019, ended Dec 31, 2019 | 1.17B |
| FY2020, ended Dec 31, 2020 | 1.17B |
| FY2021, ended Dec 31, 2021 | 1.17B |
| FY2022, ended Dec 31, 2022 | 1.13B |
| FY2023, ended Dec 31, 2023 | 1.07B |
| FY2024, ended Dec 31, 2024 | 989M |
| FY2025, ended Dec 31, 2025 | 921M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 831M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $995M | $438M | $109M |
| FY2017, ended Dec 31, 2017 | $1.01B | $733M | $144M |
| FY2018, ended Dec 31, 2018 | $3.52B | $853M | $144M |
| FY2019, ended Dec 31, 2019 | $1.41B | $1.02B | $138M |
| FY2020, ended Dec 31, 2020 | $1.64B | $1.38B | $137M |
| FY2021, ended Dec 31, 2021 | $3.37B | $1.38B | $162M |
| FY2022, ended Dec 31, 2022 | $4.20B | $1.26B | $143M |
| FY2023, ended Dec 31, 2023 | $5.00B | $1.48B | $127M |
| FY2024, ended Dec 31, 2024 | $6.05B | $1.23B | $95.0M |
| FY2025, ended Dec 31, 2025 | $6.05B | $1.00B | $117M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $6.05B | $977M | $103M |
Valuation
At current price- Market Cap
- $46.6B
- P/E
- 9.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.4×
- Price / Book
- 2.4×
- EV / EBITDA
- 7.8×
Growth
Trailing 12 months- Revenue (TTM)
- $34.3B
- Revenue Growth YoY
- 4.4%
- Revenue CAGR 3Y
- 6.4%
- Revenue CAGR 5Y
- 9.1%
- EPS Growth YoY
- 5.2%
- Net Income Growth YoY
- −3.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 17.0%
- Net Margin
- 13.8%
- FCF Margin
- 18.4%
- Return on Equity
- 23.8%
Earnings
Trailing 12 months- Net Income
- $4.73B
- EPS (diluted)
- $5.24
- EBITDA
- $6.80B
- Operating Income
- $5.83B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $7.16B
- Total Debt
- $13.6B
- Net Debt
- $6.39B
- Total Assets
- $81.6B
- Total Liabilities
- $62.1B
- Shareholders' Equity
- $19.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $7.09B
- Capital Expenditure
- $794M
- Free Cash Flow
- $6.30B
Dividends and risk
Last 12 months- Dividend Yield
- 1.0%
- Dividend / Share
- $0.56
- Beta (5Y)
- 1.27
Every ratio is calculated from the company’s reported figures.